Skip to main content
OpenTrials
Completed

NCT Number: NCT03244007

Evaluation of Retinal Microstructure Detected With Intraoperative Optical Coherence Tomography During Vitrectomy

We evaluate the intraoperative optical coherence tomographic (OCT) images of eyes with idiopathic macular hole (MH) or lamellar macular hole whether the intraoperative OCT findings will affect postoperative visual outcome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Makoto Inoue

Mitaka-shi, Tokyo, 181-8611, Japan

About this study

We evaluate the intraoperative optical coherence tomographic (OCT) images of eyes with idiopathic macular hole (MH) or lamellar macular hole whether the intraoperative OCT findings will affect postoperative visual outcome.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Eyes with macular hole or lamellar macular hole -

Exclusion criteria

Eyes with retinal detachment, retinal vascular disease, glaucoma

-

Treatment and study plan

Vitrectomy

Procedure

Primary outcomes

  1. Recovery of microstructure

    Time frame: 6 months

Secondary outcomes

  1. Visual improvement

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Kyorin University

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2017
First posted
Aug 9, 2017
Registry last updated
Feb 20, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.